Search Results 681-690 of 19250 for hemoglobin

1. A Study to Evaluate Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration In HPV Head And Neck Cancer - Mayo Clinic

   Hemoglobin ≥8.0g/dL;; Creatinine ≤ 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; Total or direct bilirubin < 2 x institutional upper limit of normal (ULN); ...

2. Study of Canakinumab in Patients With Myelofibrosis - Mayo Clinic

   - Hemoglobin < 10 g/dL; - Transfusion-dependency (at least 6 units of packed red blood cells (PRBC) in the 12 weeks prior to study enrollment, for a ...

3. A Study of Minimally Invasive Pericardiotomy as a New Treatment for Heart Failure - Mayo Clinic

   Any hemoglobin (Hgb) < 8.0 g/dl within 30 days prior to randomization. Any GFR < 20 ml/min/1.73 m2 within 30 days prior to randomization. Significant ...

4. Radiation Therapy With or Without Bicalutamide in Treating Patients With Stage II, Stage III, or Recurrent Prostate Cancer - Mayo Clinic

   Hemoglobin at least 10 g/dL. Hepatic: Bilirubin normal; Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) no greater than 2.5 times normal.

5. A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Disease (PF-ILDs) - Mayo Clinic

   DLCO ≥ 25% of predicted normal corrected for hemoglobin (Hb) at Visit 1. 7. Women of childbearing potential (WOCBP) must be ready and able to use highly ...

6. Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET - Mayo Clinic

   * Hemoglobin (Hb) ≥ 8 g/dL * Creatinine clearance \> 40 mL/min calculated by the Cockcroft Gault method * Total bilirubin ≤ 3 x ULN * Potassium within ...

7. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Platelet count ≥ 100,000/mL. Bilirubin ≤ 1.5 mg/dL ... Patients previously diagnosed with diabetes must not have uncontrolled diabetes ( ...

8. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

   ... hemoglobin (HGB) <10 g/dL at any dose and any duration of HU, or Presence of HU-related toxicities at any dose and any duration of therapy (e.g., leg ulcers ...

9. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

   Hemoglobin must be greater than or equal to 12.0 in males and 11.0 in females. Subjects with previous biopsy proven and/or MRE proven NASH will be included ...

10. Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy - Mayo Clinic

    -Hemoglobin >= 7.0 g/dL if asymptomatic or hemoglobin > 8 if symptomatic; transfusion support allowed, if necessary (obtained =< 14 days prior to registration).